Efficacy and Safety of Different Doses of Venus Association in Patients With Vulvovaginal Candidiasis.

Inclusion Criteria: * Ability to confirm voluntary participation and agree to all trial purposes by signing and dating the informed consent forms; * Age greater than or equal to 18 years; * Female participants, post-menarche; * Clinical diagnosis of vulvovaginal candidiasis, defined as white, fluid or creamy vaginal discharge, in addition to the following findings: * Itching and one or more of the following signs and symptoms characterized as moderate or severe: vulvar/vaginal erythema, edema, burning, irritation, and excoriation; * Normal vaginal pH; * Preparation of KOH or saline from a sample taken from inflamed vaginal mucosa or secretions revealing yeast forms (hyphae or pseudohyphae) or growing yeast. Exclusion Criteria: * Any clinical and laboratory findings that, in the judgment of the investigator, may interfere with the safety of research participants; * Participation in a clinical trial in the year prior to this study; * Pregnancy or risk of pregnancy and lactating patients; * Known hypersensitivity to any of the formula compounds; * Virgin participants; * Postmenopausal participants or with vaginal atrophy; * Participants with other vaginal infections; * Participants with recurrent vulvovaginal candidiasis; * Participants using immunosuppressive drugs; * Participants diagnosed with serious systemic diseases.